Piramal Pharma is building out manufacturing capacity and adding more specialized medicines, aiming to benefit as more drugmakers outsource production and healthcare demand rises worldwide. The big question is whether it can grow without getting squeezed by a few key customers, tough regulation, pricing pressure, and heavy spending that limits flexibility.Read more
Catalysts About Piramal Pharma Piramal Pharma operates a diversified pharmaceuticals platform spanning CDMO services, complex hospital generics and consumer healthcare brands. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Piramal Pharma Piramal Pharma is a diversified pharmaceutical company focused on contract development and manufacturing, complex hospital generics and consumer healthcare brands. What are the underlying business or industry changes driving this perspective?Read more
Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.
